| Year |
Citation |
Score |
| 2001 |
Weishaupt A, Schönrock LM, Stienekemeier M, Toyka KV, Gold R. Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ Acta Neuropathologica. 102: 75-82. PMID 11547954 DOI: 10.1007/S004010000356 |
0.3 |
|
| 2000 |
Schneider C, Matsumoto Y, Kohyama K, Toyka KV, Hartung HP, Gold R. Experimental autoimmune myositis in the Lewis rat: lack of spontaneous T-cell apoptosis and therapeutic response to glucocorticosteroid application Journal of Neuroimmunology. 107: 83-87. PMID 10808054 DOI: 10.1016/S0165-5728(00)00254-X |
0.344 |
|
| 1998 |
Naumann M, Toyka KV, Mansouri Taleghani B, Ahmadpour J, Reiners K, Bigalke H. Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin. Journal of Neurology, Neurosurgery, and Psychiatry. 65: 924-7. PMID 9854974 DOI: 10.1136/Jnnp.65.6.924 |
0.309 |
|
| 1998 |
Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Annals of Neurology. 44: 780-8. PMID 9818934 DOI: 10.1002/Ana.410440512 |
0.314 |
|
| 1998 |
Enders U, Lobb R, Pepinsky RB, Hartung HP, Toyka KV, Gold R. The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat. Brain : a Journal of Neurology. 121: 1257-66. PMID 9679778 DOI: 10.1093/Brain/121.7.1257 |
0.416 |
|
| 1998 |
Kiefer R, Kieseier BC, Brück W, Hartung HP, Toyka KV. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain. 121: 469-479. PMID 9549523 DOI: 10.1093/Brain/121.3.469 |
0.387 |
|
| 1997 |
Weilbach FX, Jung S, Hartung H-, Toyka KV, Giegerich G. T-cell receptor Vβ-element expression in peripheral nerves of Lewis rats suffering from experimental autoimmune neuritis Journal of Neuroimmunology. 79: 69-75. PMID 9357449 DOI: 10.1016/S0165-5728(97)00112-4 |
0.416 |
|
| 1997 |
Enders U, Toyka KV, Hartung H-, Gold R. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat. Journal of Neuroimmunology. 76: 112-116. PMID 9184640 DOI: 10.1016/S0165-5728(97)00039-8 |
0.328 |
|
| 1996 |
Gold R, Schmied M, Tontsch U, Hartung HP, Wekerle H, Toyka KV, Lassmann H. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo. Brain : a Journal of Neurology. 119: 651-9. PMID 8800954 DOI: 10.1093/Brain/119.2.651 |
0.356 |
|
| 1995 |
Weishaupt A, Giegerich G, Jung S, Gold R, Enders U, Pette M, Hayasaka K, Hartung H-, Toyka KV. T cell antigenic and neuritogenic activity of recombinant human peripheral myelin P2 protein Journal of Neuroimmunology. 63: 149-156. PMID 8550812 DOI: 10.1016/0165-5728(95)00139-5 |
0.395 |
|
| 1995 |
Pollard JD, Westland KW, Harvey GK, Jung S, Bonner J, Spies JM, Toyka KV, Hartung HP. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Annals of Neurology. 37: 467-75. PMID 7717683 DOI: 10.1002/Ana.410370409 |
0.425 |
|
| 1995 |
Zielasek J, Jung S, Gold R, Liew FY, Toyka KV, Hartung HP. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis Journal of Neuroimmunology. 58: 81-88. PMID 7537283 DOI: 10.1016/0165-5728(94)00192-Q |
0.334 |
|
| 1995 |
Harvey GK, Gold R, Hartung H-, Toyka KV. Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain. 118: 1263-1272. PMID 7496785 DOI: 10.1093/Brain/118.5.1263 |
0.433 |
|
| 1994 |
Pette M, Linington C, Gengaroli C, Grosse-Wilde H, Toyka KV, Hartung HP. T lymphocyte recognition sites on peripheral nerve myelin P0 protein Journal of Neuroimmunology. 54: 29-34. PMID 7523445 DOI: 10.1016/0165-5728(94)90227-5 |
0.38 |
|
| 1994 |
Pette M, Gengaroli C, Hartung HP, Greiner A, Giegerich G, Toyka KV. Human T lymphocytes distinguish bovine from human P2 peripheral myelin protein: implications for immunological studies on inflammatory demyelinating neuropathies. Journal of Neuroimmunology. 52: 47-52. PMID 7515899 DOI: 10.1016/0165-5728(94)90161-9 |
0.391 |
|
| 1994 |
Harvey GK, Gold R, Toyka KV, Hartung H-. Peripheral neuropathy orchestrated by nonneural-specific lymphocytes Journal of Neuroimmunology. 54: 167. DOI: 10.1016/0165-5728(94)90350-6 |
0.368 |
|
| 1994 |
Gold R, Schmied M, Tontsch U, Hartung HP, Wekerle H, Toyka KV, Lassmann H. Antigen presentation by astrocytes primes rat T-lymphocytes for apoptotic cell death Journal of Neuroimmunology. 54: 164. DOI: 10.1016/0165-5728(94)90335-2 |
0.341 |
|
| 1994 |
Giegerich G, Weilbach F, Gold R, Toyka KV, Hartung HP. T cell receptor Vβ sequence analysis in target tissue suggests contribution of myelin basic protein autoreactivity to experimental allergic neuritis Journal of Neuroimmunology. 54: 163. DOI: 10.1016/0165-5728(94)90327-1 |
0.328 |
|
| 1993 |
Archelos JJ, Roggenbuck K, Scheider-Schaulies J, Linington C, Toyka KV, Hartung H-. Production and characterization of monoclonal antibodies to the extracellular domain of P0. Journal of Neuroscience Research. 35: 46-53. PMID 7685397 DOI: 10.1002/Jnr.490350107 |
0.351 |
|
| 1992 |
Hömberg V, Reiners K, Toyka KV. Reversible conduction block in human ischemic neuropathy after ergotamine abuse. Muscle & Nerve. 15: 467-70. PMID 1314328 DOI: 10.1002/Mus.880150409 |
0.335 |
|
| 1991 |
Toyka KV, Hartung HP, Schmidt B, Stoll G, Archelos JJ, Zielasek J. Immune-mediated peripheral nerve disorders Journal of Neuroimmunology. 35: 11. DOI: 10.1016/0165-5728(91)90850-7 |
0.332 |
|
| 1990 |
Schmidt B, Stoll G, Hartung H, Heininger K, Schäfer B, Toyka KV. Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis. Annals of Neurology. 28: 70-77. PMID 2375636 DOI: 10.1002/Ana.410280113 |
0.388 |
|
| 1990 |
Hartung H, Schäfer B, Meide PHVD, Fierz W, Heininger K, Toyka KV. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Annals of Neurology. 27: 247-257. PMID 2158267 DOI: 10.1002/Ana.410270306 |
0.406 |
|
| 1989 |
Tesch H, Hohlfeld R, Toyka KV. Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patients. Journal of Neuroimmunology. 21: 169-176. PMID 2783584 DOI: 10.1016/0165-5728(89)90172-0 |
0.321 |
|
| 1989 |
Seitz RJ, Reiners K, Himmelmann F, Heininger K, Hartung HP, Toyka KV. The blood-nerve barrier in Wallerian degeneration: a sequential long-term study. Muscle & Nerve. 12: 627-35. PMID 2506446 DOI: 10.1002/Mus.880120803 |
0.52 |
|
| 1989 |
Hartung HP, Schäfer B, Diamantstein T, Fierz W, Heininger K, Toyka KV. Suppression of P2-T-cell line mediated experimental autoimmune neuritis by interleukin-2 receptor blockade. Annals of the New York Academy of Sciences. 540: 563-5. PMID 2462831 DOI: 10.1111/J.1749-6632.1988.Tb27173.X |
0.343 |
|
| 1988 |
Hartung HP, Heininger K, Toyka KV. Primary rat astroglial cultures can generate leukotriene B4. Journal of Neuroimmunology. 19: 237-43. PMID 2842377 DOI: 10.1016/0165-5728(88)90005-7 |
0.304 |
|
| 1988 |
Fierz W, Heininger K, Schaefer B, Toyka KV, Linington C, Lassmann H. Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galactocerebroside or a myelin oligodendroglial glycoprotein. Annals of the New York Academy of Sciences. 540: 360-363. PMID 2462812 DOI: 10.1111/J.1749-6632.1988.Tb27099.X |
0.397 |
|
| 1988 |
Hartung HP, Schäfer B, Fierz W, Heininger K, Toyka KV. Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat. Neuroscience Letters. 83: 195-200. PMID 2450307 DOI: 10.1016/0304-3940(87)90240-0 |
0.42 |
|
| 1987 |
Hohlfeld R, Toyka KV, Michels M, Heininger K, Conti-Tronconi B, Tzartos SJ. Acetylcholine receptor-specific human T-lymphocyte lines. Annals of the New York Academy of Sciences. 505: 27-38. PMID 2446551 DOI: 10.1111/J.1749-6632.1987.Tb51280.X |
0.311 |
|
| 1987 |
Toyka KV, Heininger K. Humoral factors in peripheral nerve disease Muscle & Nerve. 10: 222-232. PMID 2436046 DOI: 10.1002/Mus.880100305 |
0.381 |
|
| 1987 |
Hohlfeld R, Michels M, Tesch H, Fahsbender A, Heininger K, Conti-Tronconi B, Toyka KV. In Vitro Propagation of Acetylcholine Receptor‐Specific Human T Lymphocytes with Autologous Epstein‐Barr Virus‐Transformed B Lymphocytesa Annals of the New York Academy of Sciences. 505: 693-694. DOI: 10.1111/J.1749-6632.1987.Tb51340.X |
0.302 |
|
| 1987 |
Hartung HP, Schäfer B, Fierz W, Heininger K, Diamantstein T, Toyka KV. Suppression of P2-T cell-line mediated experimental autoimmune neuritis by interleukin 2 — Receptor blockade Journal of Neuroimmunology. 16: 73. DOI: 10.1016/0165-5728(87)90240-2 |
0.343 |
|
| 1987 |
Fierz W, Heininger K, Schaefer B, Toyka KV, Linington C, Lassmann H. Synergism in the pathogenesis of EAE induced by an MBP-specific T cell line and monoclonal antibodies to Galacto-Cerebroside or to a myelin oligodendroglial glycoprotein Journal of Neuroimmunology. 16: 55-56. DOI: 10.1016/0165-5728(87)90213-X |
0.396 |
|
| 1986 |
Stoll G, Reiners K, Schwendemann G, Heininger K, Toyka KV. Normal myelination of regenerating peripheral nerve sprouts despite circulating antibodies to galactocerebroside in rabbits. Annals of Neurology. 19: 189-92. PMID 3963761 DOI: 10.1002/Ana.410190213 |
0.385 |
|
| 1986 |
Stoll G, Schwendemann G, Heininger K, Köhne W, Hartung HP, Seitz R, Toyka KV. Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis. Journal of Neurology, Neurosurgery, and Psychiatry. 49: 258-64. PMID 3958739 DOI: 10.1136/Jnnp.49.3.258 |
0.535 |
|
| 1986 |
Hohlfeld R, Michels M, Tesch H, Fahsbender A, Heininger K, Contitronconi BM, Toyka KV. Epstein−Barr virus-transformed B cells can present acetyl-choline receptor to autologous autoreactive T cells Immunology Letters. 12: 171-174. PMID 3013761 DOI: 10.1016/0165-2478(86)90101-X |
0.313 |
|
| 1986 |
Heininger K, Stoll G, Linington C, Toyka KV, Wekerle H. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines. Annals of Neurology. 19: 44-9. PMID 2418761 DOI: 10.1002/Ana.410190109 |
0.405 |
|
| 1985 |
Seitz RJ, Heininger K, Schwendemann G, Toyka KV, Wechsler W. The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system. Acta Neuropathologica. 68: 15-21. PMID 3901654 DOI: 10.1007/Bf00688950 |
0.519 |
|
| 1985 |
Steck AJ, Murray N, Justafre JC, Meier C, Toyka KV, Heininger K, Stoll G. Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein. Journal of Neurology, Neurosurgery, and Psychiatry. 48: 927-929. PMID 2413173 DOI: 10.1136/Jnnp.48.9.927 |
0.369 |
|
| 1985 |
Stoll G, Schwendemann G, Heininger K, Steck AJ, Toyka KV. Human monoclonal anti-MAG antibody and anti-Leu 7 recognise shared antigenic determinants in peripheral nerve and spinal cord. Journal of Neurology, Neurosurgery, and Psychiatry. 48: 635-8. PMID 2411873 DOI: 10.1136/Jnnp.48.7.635 |
0.395 |
|
| 1985 |
Hohlfeld R, Toyka KV. Strategies for the modulation of neuroimmunological disease at the level of autoreactive T-lymphocytes Journal of Neuroimmunology. 9: 193-204. PMID 2410450 DOI: 10.1016/S0165-5728(85)80018-7 |
0.376 |
|
| 1984 |
Hohlfeld R, Toyka KV, Heininger K, Grosse-Wilde H, Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor Nature. 310: 244-246. PMID 6611507 DOI: 10.1038/310244A0 |
0.378 |
|
| 1984 |
Seitz RJ, Toyka KV, Wechsler W. Adult-onset mixed myopathy with nemaline rods, minicores, and central cores: a muscle disorder mimicking polymyositis Journal of Neurology. 231: 103-108. PMID 6481414 DOI: 10.1007/Bf00313674 |
0.445 |
|
| 1980 |
Toyka KV, Löwenadler B, Heininger K, Besinger UA, Birnberger KL, Fateh-Moghadam A, Heilbronn E. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG. Journal of Neurology, Neurosurgery, and Psychiatry. 43: 836-842. PMID 6252294 DOI: 10.1136/Jnnp.43.9.836 |
0.323 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1988 |
Hartung H, Schäfer B, Heininger K, Toyka KV. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase. Annals of Neurology. 23: 453-460. PMID 3260463 DOI: 10.1002/Ana.410230505 |
0.296 |
|
| 1995 |
Pette M, Gold R, Pette DF, Hartung H, Toyka KV. Mafosfamide induces DNA fragmentation and apoptosis in human T-lymphocytes A possible mechanism of its immunosuppressive action Immunopharmacology. 30: 59-69. PMID 7591714 DOI: 10.1016/0162-3109(95)00005-E |
0.295 |
|
| 1991 |
Hartung H, Reiners K, Schmidt B, Stoll G, Toyka KV. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: Comparison with other neurological diseases of presumed immunopathogenesis Annals of Neurology. 30: 48-53. PMID 1929228 DOI: 10.1002/Ana.410300110 |
0.288 |
|
| 2005 |
Jung S, Zimmer S, Lüneberg E, Frosch M, Karch H, Korn T, Toyka KV. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome? Neuroscience Letters. 381: 175-8. PMID 15882812 DOI: 10.1016/j.neulet.2005.02.028 |
0.284 |
|
| 2003 |
Chan A, Seguin R, Magnus T, Papadimitriou C, Toyka KV, Antel JP, Gold R. Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta. Glia. 43: 231-42. PMID 12898702 DOI: 10.1002/Glia.10258 |
0.283 |
|
| 1981 |
Besinger UA, Toyka KV, Heininger K, Fateh-Moghadam A, Schumm F, Sandel P, Birnberger KL. Long‐Term Correlation Of Clinical Course And Acetylcholine Receptor Antibody In Patients With Myasthenia Gravis Annals of the New York Academy of Sciences. 377: 812-815. DOI: 10.1111/J.1749-6632.1981.Tb33781.X |
0.28 |
|
| 1988 |
Hohlfeld R, Toyka KV, Miner LL, Conti-Tronconi BM. Stimulation of autoimmune helper T lymphocytes from patients with myasthenia gravis with synthetic peptides of the acetylcholine receptor alpha subunit. Annals of the New York Academy of Sciences. 540: 511-512. PMID 2462826 DOI: 10.1111/J.1749-6632.1988.Tb27154.X |
0.278 |
|
| 2002 |
Leussink VI, Zettl UK, Jander S, Pepinsky RB, Lobb RR, Stoll G, Toyka KV, Gold R. Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis Acta Neuropathologica. 103: 131-136. PMID 11810178 DOI: 10.1007/s004010100444 |
0.277 |
|
| 2003 |
Chan A, Papadimitriou C, Graf W, Toyka KV, Gold R. Effects of polyclonal immunoglobulins and other immunomodulatory agents on microglial phagocytosis of apoptotic inflammatory T-cells. Journal of Neuroimmunology. 135: 161-5. PMID 12576237 DOI: 10.1016/S0165-5728(02)00433-2 |
0.277 |
|
| 2003 |
Schmidt J, Elflein K, Stienekemeier M, Rodriguez-Palmero M, Schneider C, Toyka KV, Gold R, Hünig T. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. Journal of Neuroimmunology. 140: 143-52. PMID 12864982 DOI: 10.1016/S0165-5728(03)00182-6 |
0.275 |
|
| 1988 |
Hartung HP, Heininger K, Schäfer B, Toyka KV. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. The Faseb Journal. 2: 48-51. PMID 2446942 DOI: 10.1096/Fasebj.2.1.2446942 |
0.272 |
|
| 2013 |
Camara M, Beyersdorf N, Fischer HJ, Herold MJ, Ip CW, van den Brandt J, Toyka KV, Taurog JD, Hünig T, Herrmann T, Reichardt HM, Weishaupt A, Kerkau T. CD8⺠T cell help is required for efficient induction of EAE in Lewis rats. Journal of Neuroimmunology. 260: 17-27. PMID 23664330 DOI: 10.1016/j.jneuroim.2013.04.014 |
0.271 |
|
| 2004 |
Korn T, Magnus T, Toyka K, Jung S. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion. Journal of Leukocyte Biology. 76: 950-60. PMID 15328336 DOI: 10.1189/jlb.0504308 |
0.267 |
|
| 2002 |
Mäurer M, Toyka KV, Gold R. Cellular immunity in inflammatory autoimmune neuropathies Revue Neurologique. 158: 6S7-6S15. PMID 12690655 |
0.267 |
|
| 2012 |
Horn M, Baumann R, Pereira JA, Sidiropoulos PN, Somandin C, Welzl H, Stendel C, Lühmann T, Wessig C, Toyka KV, Relvas JB, Senderek J, Suter U. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain : a Journal of Neurology. 135: 3567-83. PMID 23171661 DOI: 10.1093/Brain/Aws275 |
0.267 |
|
| 1989 |
Hartung H, Toyka KV. Substance P, the Immune System and Inflammation International Reviews of Immunology. 4: 229-249. PMID 2484943 DOI: 10.3109/08830188909054420 |
0.266 |
|
| 1981 |
Löwenadler B, Toyka KV, Heininger K, Besinger UA, Heilbronn E. Protection Of End Plates By Fab Fragments From Human Myasthenic Igg In The Mouse Transfer Model Annals of the New York Academy of Sciences. 377: 842-843. DOI: 10.1111/J.1749-6632.1981.Tb33795.X |
0.265 |
|
| 2006 |
Hofstetter HH, Toyka KV, Gold R. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis. Neuroscience Letters. 391: 127-30. PMID 16198481 DOI: 10.1016/j.neulet.2005.08.042 |
0.257 |
|
| 1988 |
Hartung HP, Toyka KV. Leukotriene production by cultured astroglial cells. Brain Research. 435: 367-70. PMID 3123012 DOI: 10.1016/0006-8993(87)91627-1 |
0.257 |
|
| 2001 |
Magnus T, Chan A, Grauer O, Toyka KV, Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation Journal of Immunology. 167: 5004-5010. PMID 11673508 DOI: 10.4049/Jimmunol.167.9.5004 |
0.257 |
|
| 2001 |
Stienekemeier M, Falk K, Rötzschke O, Weishaupt A, Schneider C, Toyka KV, Gold R, Strominger JL. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope. Proceedings of the National Academy of Sciences of the United States of America. 98: 13872-7. PMID 11717443 DOI: 10.1073/Pnas.241504598 |
0.256 |
|
| 2000 |
Kieseier BC, Krivacic K, Jung S, Pischel H, Toyka KV, Ransohoff RM, Hartung HP. Sequential expression of chemokines in experimental autoimmune neuritis Journal of Neuroimmunology. 110: 121-129. PMID 11024541 DOI: 10.1016/S0165-5728(00)00323-4 |
0.256 |
|
| 2005 |
Berghoff M, Samsam M, Müller M, Kobsar I, Toyka KV, Kiefer R, Mäurer M, Martini R. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene. Molecular and Cellular Neurosciences. 28: 118-27. PMID 15607947 DOI: 10.1016/j.mcn.2004.09.001 |
0.255 |
|
| 1983 |
Hartung HP, Toyka KV. Activation of macrophages by substance P: Induction of oxidative burst and thromboxane release European Journal of Pharmacology. 89: 301-305. PMID 6191998 DOI: 10.1016/0014-2999(83)90511-3 |
0.255 |
|
| 2006 |
Tischner D, Weishaupt A, van den Brandt J, Müller N, Beyersdorf N, Ip CW, Toyka KV, Hünig T, Gold R, Kerkau T, Reichardt HM. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain : a Journal of Neurology. 129: 2635-47. PMID 16921176 DOI: 10.1093/Brain/Awl213 |
0.253 |
|
| 1988 |
Heininger K, Fierz W, Schäfer B, Hartung H, Toyka KV. Adoptive Transfer Experimental Autoimmune Encephalomyelitis Annals of the New York Academy of Sciences. 540: 738-740. PMID 3264689 DOI: 10.1111/J.1749-6632.1988.Tb27231.X |
0.253 |
|
| 1988 |
Toyka KV, Hartung H-, Schäfer B, Heininger K, Fierz W. Immune mechanisms in acute and chronic inflammatory polyneuropathies. Journal of Neuroimmunology. 20: 277-281. PMID 2848862 DOI: 10.1016/0165-5728(88)90175-0 |
0.252 |
|
| 2004 |
Weilbach FX, Chan A, Toyka KV, Gold R. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis Clinical and Experimental Immunology. 135: 49-55. PMID 14678264 DOI: 10.1111/J.1365-2249.2004.02344.X |
0.252 |
|
| 2003 |
Kobsar I, Berghoff M, Samsam M, Wessig C, Mäurer M, Toyka KV, Martini R. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1 Brain. 126: 804-813. PMID 12615640 DOI: 10.1093/brain/awg072 |
0.251 |
|
| 1989 |
Hartung HP, Heininger K, Schäfer B, Toyka KV. Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes. Annals of the New York Academy of Sciences. 540: 427-9. PMID 2462817 DOI: 10.1111/J.1749-6632.1988.Tb27123.X |
0.244 |
|
| 1987 |
Hartung HP, Heininger K, Schäfer B, Toyka KV. Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes Journal of Neuroimmunology. 16: 72. DOI: 10.1016/0165-5728(87)90239-6 |
0.244 |
|
| 1998 |
Previtali S, Archelos JJ, Toyka KV, Hartung H-. Expression of integrins in experimental autoimmune neuritis and Guillain-Barre syndrome Journal of Neuroimmunology. 90: 87. DOI: 10.1016/S0165-5728(98)91700-3 |
0.244 |
|
| 2001 |
Gold R, Reiners K, Toyka KV. Immunoglobulins in the treatment of neuromuscular autoimmune disorders | Therapie mit immunglobulinen bei neuromuskulären autoimmunerkrankungen Nervenheilkunde. 20: 287-294. |
0.244 |
|
| 2002 |
Mäurer M, Toyka KV, Gold R. Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscular Disorders : Nmd. 12: 405-14. PMID 12062260 DOI: 10.1016/S0960-8966(01)00302-9 |
0.244 |
|
| 2002 |
Beck M, Giess R, Magnus T, Puls I, Reiners K, Toyka KV, Naumann M. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis Journal of Neurology Neurosurgery and Psychiatry. 73: 68-70. PMID 12082050 DOI: 10.1136/Jnnp.73.1.68 |
0.242 |
|
| 2001 |
Schneider C, Reiners K, Toyka KV. Steinert's disease and Ricker's syndrome: Mytonic muscular disorders with multisystemic manifestations | Myotone dystrophie (DM/Curschmann-Steinert-Erkrankung) und proximale myotone myopathie (PROMM/Ricker-syndrom): Myotone muskelerkrankungen mit multisystemischen manifestationen Nervenarzt. 72: 618-624. PMID 11519202 DOI: 10.1007/S001150170061 |
0.238 |
|
| 2004 |
Jung S, Gaupp S, Korn T, Köllner G, Hartung HP, Toyka KV. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization. Journal of Neuroscience Research. 75: 524-35. PMID 14743436 DOI: 10.1002/jnr.10879 |
0.238 |
|
| 2002 |
Offenhäusser M, Herr AS, Hartkamp J, Wauben M, Magnus T, Grauer O, Seubert S, Weishaupt A, Toyka KV, Gold R, Troppmair J. Truncation of the neuritogenic peptide bP2(60-70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation. Journal of Neuroimmunology. 129: 97-105. PMID 12161025 DOI: 10.1016/S0165-5728(02)00183-2 |
0.237 |
|
| 2007 |
Hofstetter HH, Grau C, Buttmann M, Forsthuber TG, Gaupp S, Toyka KV, Gold R. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. Cytokine. 40: 35-43. PMID 17881243 DOI: 10.1016/J.Cyto.2007.07.192 |
0.233 |
|
| 1995 |
Zielasek J, Jung S, Toyka KV, Hartung HP. Administration of nitric oxide (NO) synthase inhibitors in experimental autoimmune encephalomyelitis (EAE) Journal of Neuroimmunology. 63: 96. DOI: 10.1016/0165-5728(96)80968-4 |
0.233 |
|
| 2008 |
Schäfers M, Neukirchen S, Toyka KV, Sommer C. Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. Journal of the Peripheral Nervous System : Jpns. 13: 81-91. PMID 18346234 DOI: 10.1111/j.1529-8027.2008.00161.x |
0.232 |
|
| 2007 |
Siglienti I, Chan A, Kleinschnitz C, Jander S, Toyka KV, Gold R, Stoll G. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. Journal of Neuropathology and Experimental Neurology. 66: 47-56. PMID 17204936 DOI: 10.1097/nen.0b013e31802d47b4 |
0.231 |
|
| 2001 |
Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes Archives of Neurology. 58: 91-97. PMID 11176941 DOI: 10.1001/Archneur.58.1.91 |
0.23 |
|
| 2005 |
Chan A, Weilbach FX, Toyka KV, Gold R. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients Clinical and Experimental Immunology. 139: 152-158. PMID 15606626 DOI: 10.1111/J.1365-2249.2005.02653.X |
0.23 |
|
| 1987 |
Hohlfeld R, Johanns W, Fahsbender A, Toyka KV. A reliable method for immunocytochemical characterization of CSF cells. Journal of Molecular Medicine. 65: 664-666. PMID 3306137 DOI: 10.1007/Bf01875501 |
0.23 |
|
| 2008 |
Stenner MP, Waschbisch A, Buck D, Doerck S, Einsele H, Toyka KV, Wiendl H. Effects of natalizumab treatment on Foxp3+ T regulatory cells. Plos One. 3: e3319. PMID 18836525 DOI: 10.1371/journal.pone.0003319 |
0.229 |
|
| 2002 |
Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain : a Journal of Neurology. 125: 823-34. PMID 11912115 DOI: 10.1093/brain/awf070 |
0.229 |
|
| 2013 |
Kosacka J, Nowicki M, Blüher M, Baum P, Stockinger M, Toyka KV, Klöting I, Stumvoll M, Serke H, Bechmann I, Klöting N. Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Experimental Neurology. 250: 125-35. PMID 24095727 DOI: 10.1016/j.expneurol.2013.09.017 |
0.229 |
|
| 1987 |
HEININGER K, HARTUNG H, TOYKA KV, GACZKOWSKI A, BORBERG H. Therapeutic Plasma Exchange in Myasthenia Gravis: Semiselective Adsorption of Anti-AChR Autoantibodies with Tryptophane Linked Polyvinylalcohol Gels Annals of the New York Academy of Sciences. 505: 898-900. DOI: 10.1111/J.1749-6632.1987.Tb51406.X |
0.228 |
|
| 2001 |
Weishaupt A, Brück W, Hartung T, Toyka KV, Gold R. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-α Neuroscience Letters. 306: 77-80. PMID 11403962 DOI: 10.1016/S0304-3940(01)01877-8 |
0.228 |
|
| 2002 |
Magnus T, Chan A, Linker RA, Toyka KV, Gold R. Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system. Journal of Neuropathology and Experimental Neurology. 61: 760-6. PMID 12230322 DOI: 10.1093/Jnen/61.9.760 |
0.228 |
|
| 2002 |
Weishaupt A, Kuhlmann T, Schönrock LM, Toyka KV, Brück W, Gold R. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis. Acta Neuropathologica. 104: 385-90. PMID 12200625 DOI: 10.1007/S00401-002-0568-Y |
0.227 |
|
| 2009 |
Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Annals of Neurology. 66: 171-83. PMID 19705413 DOI: 10.1002/ana.21705 |
0.226 |
|
| 2001 |
Carenini S, Mäurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. The Journal of Cell Biology. 152: 301-8. PMID 11266447 DOI: 10.1083/Jcb.152.2.301 |
0.225 |
|
| 2002 |
Magnus T, Chan A, Savill J, Toyka KV, Gold R. Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. Journal of Neuroimmunology. 130: 1-9. PMID 12225883 DOI: 10.1016/S0165-5728(02)00212-6 |
0.223 |
|
| 2005 |
Mäurer M, Toyka KV, Martini R. The role of the immune system in hereditary neuropathies | Die rolle des immunsystems bei hereditären demyelinisierenden neuropathien Nervenarzt. 76: 690-700. PMID 15580468 DOI: 10.1007/s00115-004-1841-1 |
0.221 |
|
| 2005 |
Bonneick S, Boentert M, Berger P, Atanasoski S, Mantei N, Wessig C, Toyka KV, Young P, Suter U. An animal model for Charcot-Marie-Tooth disease type 4B1. Human Molecular Genetics. 14: 3685-95. PMID 16249189 DOI: 10.1093/Hmg/Ddi400 |
0.22 |
|
| 2001 |
Mäurer M, Gold R, Toyka KV, Rieckmann P. Treatment of multiple sclerosis with recombinant interferon-β preparations. Views on pharmocology and dosage | Behandlung der schubförmigen multiplen sklerose mit rekombinanten interferon-β-präparaten. Aspekte zur pharmakologie und dosierung Nervenarzt. 72: 108-116. PMID 11256144 DOI: 10.1007/S001150050722 |
0.219 |
|
| 2016 |
Grünewald B, Bennett JL, Toyka KV, Sommer C, Geis C. Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies. International Journal of Molecular Sciences. 17. PMID 27571069 DOI: 10.3390/ijms17091407 |
0.219 |
|
| 2003 |
Bayas A, Kruse N, Moriabadi NF, Weber F, Hummel V, Wohleben G, Gold R, Toyka KV, Rieckmann P. Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells Neuroscience Letters. 335: 155-158. PMID 12531456 DOI: 10.1016/S0304-3940(02)01152-7 |
0.215 |
|
| 2004 |
Martini R, Toyka KV. Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. The Lancet. Neurology. 3: 457-65. PMID 15261606 DOI: 10.1016/S1474-4422(04)00822-1 |
0.214 |
|
| 2001 |
Berciano J, Bogousslavsky J, Boon P, Comi G, Czlonkowska A, Compston DAS, Diener H-, DiDonato S, Hildebrand JG, Hohlfeld R, Krarup C, Leys D, Melamed E, Milonas I, Gaid G, ... ... Toyka K, et al. Eleventh meeting of The European Neurological Society21–25 April, 2001, Paris, France Journal of Neurology. 248: II1-II194. DOI: 10.1007/Bf03160438 |
0.213 |
|
| 2003 |
Mäurer M, Toyka KV, Gold R. Therapy of immune mediated neuropathies | Therapie immunvermittelter neuropathien Nervenheilkunde. 22: 131-135. |
0.211 |
|
| 2003 |
Schmidt J, Metselaar JM, Wauben MH, Toyka KV, Storm G, Gold R. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain : a Journal of Neurology. 126: 1895-904. PMID 12805101 DOI: 10.1093/Brain/Awg176 |
0.209 |
|
| 2012 |
Pan B, Grünewald B, Nguyen T, Farah M, Polydefkis M, McDonald J, Schramm LP, Toyka KV, Höke A, Griffin JW. The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies. Experimental Neurology. 236: 6-18. PMID 22361024 DOI: 10.1016/J.Expneurol.2012.02.006 |
0.208 |
|
| 2005 |
Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hünig T, Kerkau T, Gold R. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 202: 445-55. PMID 16061730 DOI: 10.1084/jem.20051060 |
0.206 |
|
| 2015 |
Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV. The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. Experimental Neurology. 265: 8-21. PMID 25542977 DOI: 10.1016/j.expneurol.2014.12.015 |
0.204 |
|
| 2007 |
Tersar K, Boentert M, Berger P, Bonneick S, Wessig C, Toyka KV, Young P, Suter U. Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. Human Molecular Genetics. 16: 2991-3001. PMID 17855448 DOI: 10.1093/Hmg/Ddm257 |
0.203 |
|
| 2001 |
Sommer C, Lindenlaub T, Teuteberg P, Schäfers M, Hartung T, Toyka KV. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy Brain Research. 913: 86-89. PMID 11532251 DOI: 10.1016/S0006-8993(01)02743-3 |
0.203 |
|
| 2004 |
Stoll G, Wesemeier C, Gold R, Solymosi L, Toyka KV, Bendszus M. In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging. Journal of Neuroimmunology. 149: 142-6. PMID 15020074 DOI: 10.1016/J.Jneuroim.2003.12.024 |
0.203 |
|
| 2007 |
Buchwald B, Zhang G, Vogt-Eisele AK, Zhang W, Ahangari R, Griffin JW, Hatt H, Toyka KV, Sheikh KA. Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiology of Disease. 28: 113-21. PMID 17720506 DOI: 10.1016/J.Nbd.2007.07.008 |
0.203 |
|
| 1988 |
Bell JI, Steinman L, Toyka K, McDevitt HO. HLA-DQ restriction fragment length polymorphisms in myasthenia gravis. Annals of the New York Academy of Sciences. 505: 382-7. PMID 2891337 DOI: 10.1111/J.1749-6632.1987.Tb51308.X |
0.202 |
|
| 2010 |
Schwab N, Zozulya AL, Kieseier BC, Toyka KV, Wiendl H. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 184: 5368-74. PMID 20357264 DOI: 10.4049/jimmunol.0903662 |
0.202 |
|
| 2020 |
Henzi A, Senatore A, Lakkaraju AKK, Scheckel C, Mühle J, Reimann R, Sorce S, Schertler G, Toyka KV, Aguzzi A. Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice. Plos One. 15: e0242137. PMID 33180885 DOI: 10.1371/journal.pone.0242137 |
0.198 |
|
| 2015 |
Üçeyler N, Necula G, Wagemann E, Toyka KV, Sommer C. Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy. Muscle & Nerve. PMID 26439587 DOI: 10.1002/mus.24930 |
0.197 |
|
| 2005 |
Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, Toyka KV. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet (London, England). 365: 1406-11. PMID 15836889 DOI: 10.1016/S0140-6736(05)66376-3 |
0.197 |
|
| 1988 |
Heininger K, Toyka KV. Current status of plasma exchange in Neurology Plasma Therapy and Transfusion Technology. 9: 69-72. DOI: 10.1016/0278-6222(88)90035-6 |
0.196 |
|
| 1999 |
Zielasek J, Toyka KV. Nerve Conduction Abnormalities and Neuromyotonia in Genetically Engineered Mouse Models of Human Hereditary Neuropathies. Annals of the New York Academy of Sciences. 883: 310-320. PMID 29086933 DOI: 10.1111/j.1749-6632.1999.tb08593.x |
0.194 |
|
| 2005 |
Hofstetter HH, Mössner R, Lesch KP, Linker RA, Toyka KV, Gold R. Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE Clinical and Experimental Immunology. 142: 39-44. PMID 16178854 DOI: 10.1111/j.1365-2249.2005.02901.x |
0.194 |
|
| 2005 |
Buchwald B, Ahangari R, Weishaupt A, Toyka KV. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins. Muscle & Nerve. 31: 487-94. PMID 15685615 DOI: 10.1002/mus.20269 |
0.193 |
|
| 2001 |
Buchwald B, Bufler J, Carpo M, Heidenreich F, Pitz R, Dudel J, Nobile-Orazio E, Toyka KV. Combined pre- and postsynatic action of IgG antibodies in Miller Fisher syndrome Neurology. 56: 67-74. PMID 11148238 DOI: 10.1212/WNL.56.1.67 |
0.193 |
|
| 2004 |
Kahl KG, Schmidt HH, Jung S, Sherman P, Toyka KV, Zielasek J. Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neuroscience Letters. 358: 58-62. PMID 15016434 DOI: 10.1016/j.neulet.2003.12.095 |
0.192 |
|
| 2002 |
Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nature Medicine. 8: 620-4. PMID 12042814 DOI: 10.1038/Nm0602-620 |
0.191 |
|
| 2001 |
Jung S, Gaupp S, Hartung HP, Toyka KV. Oral tolerance in experimental autoimmune neuritis (EAN) of the Lewis rat II. Adjuvant effects and bystander suppression in P2 peptide-induced EAN Journal of Neuroimmunology. 116: 21-28. PMID 11311326 DOI: 10.1016/S0165-5728(01)00276-4 |
0.191 |
|
| 2019 |
Gerber D, Ghidinelli M, Tinelli E, Somandin C, Gerber J, Pereira JA, Ommer A, Figlia G, Miehe M, Nägeli LG, Suter V, Tadini V, Sidiropoulos PN, Wessig C, Toyka KV, et al. Schwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function. Elife. 8. PMID 30648534 DOI: 10.7554/Elife.42404 |
0.191 |
|
| 2017 |
Üçeyler N, Braunsdorf S, Kunze E, Riediger N, Scheytt S, Divisova Š, Bekircan-Kurt CE, Toyka KV, Sommer C. Cellular infiltrates in skin and sural nerve of patients with polyneuropathies. Muscle & Nerve. 55: 884-893. PMID 27387067 DOI: 10.1002/mus.25240 |
0.188 |
|
| 2010 |
Boettger MK, Weishaupt A, Geis C, Toyka KV, Sommer C. Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 165-9. PMID 19946712 DOI: 10.1007/s00702-009-0342-6 |
0.187 |
|
| 2005 |
Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP Neurology. 65: 1924-1929. DOI: 10.1212/01.wnl.0000188879.19900.b7 |
0.186 |
|
| 2002 |
Buchwald B, Ahangari R, Weishaupt A, Toyka KV. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Annals of Neurology. 51: 673-80. PMID 12112071 DOI: 10.1002/ana.10205 |
0.185 |
|
| 1980 |
Toyka KV, Augspach R, Paulus W, Grabensee B, Hein D. Plasma exchange in polyradiculoneuropathy. Annals of Neurology. 8: 205-206. PMID 7425583 DOI: 10.1002/Ana.410080223 |
0.185 |
|
| 2021 |
Baum P, Koj S, Klöting N, Blüher M, Classen J, Paeschke S, Gericke M, Toyka KV, Nowicki M, Kosacka J. Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats. International Journal of Molecular Sciences. 22. PMID 33557206 DOI: 10.3390/ijms22041571 |
0.185 |
|
| 2011 |
Devigili G, Uçeyler N, Beck M, Reiners K, Stoll G, Toyka KV, Sommer C. Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment. Acta Neuropathologica. 122: 343-52. PMID 21626035 DOI: 10.1007/s00401-011-0837-8 |
0.185 |
|
| 2007 |
Toyka KV, Gold R. Treatment of myasthenia gravis Schweizer Archiv Fur Neurologie Und Psychiatrie. 158: 309-321. |
0.184 |
|
| 2002 |
Willison H, Stoll G, Toyka KV, Berger T, Hartung HP. Autoimmunity and inflammation in the peripheral nervous system. Trends in Neurosciences. 25: 127-9. PMID 11852137 DOI: 10.1016/S0166-2236(00)02120-2 |
0.182 |
|
| 2008 |
Bendszus M, Ladewig G, Jestaedt L, Misselwitz B, Solymosi L, Toyka K, Stoll G. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. Brain : a Journal of Neurology. 131: 2341-52. PMID 18669504 DOI: 10.1093/brain/awn156 |
0.18 |
|
| 2005 |
Linker RA, Rott E, Hofstetter HH, Hanke T, Toyka KV, Gold R. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiology of Disease. 19: 218-28. PMID 15837577 DOI: 10.1016/J.Nbd.2004.12.017 |
0.18 |
|
| 1988 |
Michels M, Hohlfeld R, Hartung H-, Heininger K, Besinger UA, Toyka KV. Myasthenia gravis: discontinuation of long-term azathioprine. Annals of Neurology. 24: 798-798. PMID 3207364 DOI: 10.1002/Ana.410240619 |
0.18 |
|
| 2009 |
Chuang WY, Ströbel P, Belharazem D, Rieckmann P, Toyka KV, Nix W, Schalke B, Gold R, Kiefer R, Klinker E, Opitz A, Inoue M, Kuo TT, Müller-Hermelink HK, Marx A. The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis. Genes and Immunity. 10: 667-72. PMID 19693092 DOI: 10.1038/gene.2009.64 |
0.18 |
|
| 2006 |
Stasiolek M, Bayas A, Kruse N, Wieczarkowiecz A, Toyka KV, Gold R, Selmaj K. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain : a Journal of Neurology. 129: 1293-305. PMID 16513684 DOI: 10.1093/Brain/Awl043 |
0.179 |
|
| 2005 |
Wessig C, Reiners K, Koltzenburg M, Solymosi L, Toyka KV, Stoll C, Bendszus M. MRI changes of nerve and muscle after nerve lesions: Correlation with electromyography and histology | MR-veränderungen von nerv und muskel bei läsionen des peripheren nervs: Korrelation mit elektromyographie und histologie Klinische Neurophysiologie. 36: 20-28. DOI: 10.1055/s-2004-834670 |
0.179 |
|
| 2015 |
Werner C, Pauli M, Doose S, Weishaupt A, Haselmann H, Grünewald B, Sauer M, Heckmann M, Toyka KV, Asan E, Sommer C, Geis C. Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. Brain : a Journal of Neurology. PMID 26582558 DOI: 10.1093/brain/awv324 |
0.179 |
|
| 2009 |
Ladewig G, Jestaedt L, Misselwitz B, Solymosi L, Toyka K, Bendszus M, Stoll G. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Experimental Neurology. 220: 207-11. PMID 19733560 DOI: 10.1016/j.expneurol.2009.08.027 |
0.178 |
|
| 2011 |
Sommer C, Toyka K. Nerve biopsy in chronic inflammatory neuropathies: in situ biomarkers. Journal of the Peripheral Nervous System : Jpns. 24-9. PMID 21696493 DOI: 10.1111/j.1529-8027.2011.00301.x |
0.177 |
|
| 2006 |
Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, Avila RL, Kirschner DA, Messing A, Feltri ML, Quattrini A. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2358-68. PMID 16495463 DOI: 10.1523/Jneurosci.3819-05.2006 |
0.176 |
|
| 2001 |
Moriabadi NF, Niewiesk S, Kruse N, Jung S, Weissbrich B, Ter Meulen V, Toyka KV, Rieckmann P. Influenza vaccination in MS: Absence of T-cell response against white matter proteins Neurology. 56: 938-943. PMID 11294933 |
0.175 |
|
| 2004 |
Jung S, Siglienti I, Grauer O, Magnus T, Scarlato G, Toyka K. Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate. Journal of Neuroimmunology. 148: 63-73. PMID 14975587 DOI: 10.1016/j.jneuroim.2003.11.014 |
0.175 |
|
| 2012 |
Schwab N, Ulzheimer JC, Fox RJ, Schneider-Hohendorf T, Kieseier BC, Monoranu CM, Staugaitis SM, Welch W, Jilek S, Du Pasquier RA, Brück W, Toyka KV, Ransohoff RM, Wiendl H. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology. 78: 458-67; discussion 4. PMID 22302546 DOI: 10.1212/Wnl.0B013E3182478D4B |
0.175 |
|
| 2002 |
Linker RA, Toyka KV, Gold R. EAE in genetically modified animals: Identification of targets for pathogenesis and immunotherapy of multiple sclerosis International Ms Journal. 9: 42-51. |
0.175 |
|
| 2003 |
Toyka KV, Gold R. The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents. Neurology. 60: S2-7. PMID 12707416 DOI: 10.1212/Wnl.60.8_Suppl_3.S2 |
0.173 |
|
| 2005 |
Reinhardt M, Hauff P, Linker RA, Briel A, Gold R, Rieckmann P, Becker G, Toyka KV, Mäurer M, Schirner M. Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ). Neuroimage. 27: 267-78. PMID 15905104 DOI: 10.1016/j.neuroimage.2005.04.019 |
0.171 |
|
| 2001 |
Mäurer M, Schmid CD, Bootz F, Zielasek J, Toyka KV, Oehen S, Martini R. Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Molecular and Cellular Neurosciences. 17: 1094-101. PMID 11414797 DOI: 10.1006/mcne.2001.0990 |
0.17 |
|
| 2010 |
Uçeyler N, Devigili G, Toyka KV, Sommer C. Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathologica. 120: 109-16. PMID 20204385 DOI: 10.1007/s00401-010-0662-5 |
0.17 |
|
| 2010 |
Geis C, Weishaupt A, Hallermann S, Grünewald B, Wessig C, Wultsch T, Reif A, Byts N, Beck M, Jablonka S, Boettger MK, Üçeyler N, Fouquet W, Gerlach M, Meinck HM, ... ... Toyka KV, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain : a Journal of Neurology. 133: 3166-80. PMID 20884644 DOI: 10.1093/Brain/Awq253 |
0.168 |
|
| 2013 |
Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. The Journal of Physiology. 591: 2747-62. PMID 23440963 DOI: 10.1113/Jphysiol.2013.251827 |
0.167 |
|
| 2010 |
Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave KA, Weis J, Aguzzi A. Axonal prion protein is required for peripheral myelin maintenance. Nature Neuroscience. 13: 310-8. PMID 20098419 DOI: 10.1038/Nn.2483 |
0.166 |
|
| 2015 |
Steinbeck JA, Jaiswal MK, Calder EL, Kishinevsky S, Weishaupt A, Toyka KV, Goldstein PA, Studer L. Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease. Cell Stem Cell. PMID 26549107 DOI: 10.1016/J.Stem.2015.10.002 |
0.163 |
|
| 2001 |
Wessig C, Buchwald B, Toyka KV, Martini R. Miller Fisher syndrome: Immunofluorescence and immunoelectron microscopic localization of IgG at the mouse neuromuscular junction Acta Neuropathologica. 101: 239-244. PMID 11307623 |
0.16 |
|
| 2003 |
Wessig C, Klein R, Schneider MF, Toyka KV, Naumann M, Sommer C. Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology. 61: 195-8. PMID 12874398 |
0.159 |
|
| 2013 |
Hansen N, Grünewald B, Weishaupt A, Colaço MN, Toyka KV, Sommer C, Geis C. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Experimental Neurology. 239: 202-9. PMID 23099416 DOI: 10.1016/j.expneurol.2012.10.013 |
0.159 |
|
| 2012 |
Geis C, Grünewald B, Weishaupt A, Wultsch T, Toyka KV, Reif A, Sommer C. Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 981-5. PMID 22331304 DOI: 10.1007/S00702-012-0773-3 |
0.158 |
|
| 2004 |
Visan L, Visan IA, Weishaupt A, Hofstetter HH, Toyka KV, Hünig T, Gold R. Tolerance induction by intrathymic expression of P0. Journal of Immunology (Baltimore, Md. : 1950). 172: 1364-70. PMID 14734711 DOI: 10.4049/Jimmunol.172.3.1364 |
0.158 |
|
| 2015 |
Üçeyler N, Geng A, Reiners K, Toyka KV, Sommer C. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. Journal of Neurology. 262: 2092-100. PMID 26092519 DOI: 10.1007/s00415-015-7813-5 |
0.157 |
|
| 2000 |
Weishaupt A, Jander S, Bruck W, Kuhlmann T, Stienekemeier M, Hartung T, Toyka KV, Stoll G, Gold R. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase Journal of Immunology. 165: 7157-7163. PMID 11120847 DOI: 10.4049/Jimmunol.165.12.7157 |
0.157 |
|
| 2003 |
Krampfl K, Mohammadi B, Buchwald B, Jahn K, Dengler R, Toyka KV, Bufler J. IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels Muscle and Nerve. 27: 435-441. PMID 12661044 DOI: 10.1002/mus.10349 |
0.157 |
|
| 2001 |
Grauer O, Offenhäusser M, Schmidt J, Toyka KV, Gold R. Glucocorticosteroid therapy in optic neuritis and multiple sclerosis: Evidence from clinical studies and practical recommendations | Glukokortikosteroid-therapie bei optikusneuritis und multipler sklerose: Evidenz aus klinischen studien und praktische empfehlungen Nervenarzt. 72: 577-589. PMID 11519198 DOI: 10.1007/s001150170057 |
0.157 |
|
| 2001 |
Schmidt J, Stürzebecher S, Toyka KV, Gold R. Interferon-β treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration Journal of Neuroscience Research. 65: 59-57. PMID 11433430 DOI: 10.1002/jnr.1128 |
0.157 |
|
| 2003 |
Kahl KG, Zielasek J, Uttenthal LO, Rodrigo J, Toyka KV, Schmidt HH. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. Journal of Neuroscience Research. 73: 198-205. PMID 12836162 DOI: 10.1002/jnr.10649 |
0.157 |
|
| 2001 |
Kruse N, Moriabadi NF, Toyka KV, Rieckmann P. Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells Journal of Immunological Methods. 247: 131-139. PMID 11150544 DOI: 10.1016/S0022-1759(00)00316-1 |
0.154 |
|
| 2009 |
Bayas A, Stasiolek M, Kruse N, Toyka KV, Selmaj K, Gold R. Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis Clinical and Experimental Immunology. 157: 332-342. PMID 19664140 DOI: 10.1111/j.1365-2249.2009.03964.x |
0.153 |
|
| 2001 |
Sommer C, Schäfers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy Journal of the Peripheral Nervous System. 6: 67-72. PMID 11446385 DOI: 10.1046/j.1529-8027.2001.01010.x |
0.153 |
|
| 2010 |
Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, Sommer C. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy Neurology. 74: 1806-1813. PMID 20513817 DOI: 10.1212/WNL.0b013e3181e0f7b3 |
0.153 |
|
| 2005 |
Rieckmann P, Kruse N, Nagelkerken L, Beckmann K, Miller D, Polman C, Dahlke F, Toyka KV, Hartung HP, Stürzebecher S. Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis Journal of Neurology. 252: 526-533. PMID 15895275 DOI: 10.1007/s00415-005-0681-7 |
0.152 |
|
| 2004 |
Mäurer M, Stoll G, Toyka KV. Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness. Neuromuscular Disorders : Nmd. 14: 380-2. PMID 15145341 DOI: 10.1016/j.nmd.2004.02.013 |
0.151 |
|
| 2003 |
Samsam M, Mi W, Wessig C, Zielasek J, Toyka KV, Coleman MP, Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2833-9. PMID 12684470 |
0.151 |
|
| 2008 |
Vlcková-Moravcová E, Bednarík J, Dusek L, Toyka KV, Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle & Nerve. 37: 50-60. PMID 17763459 DOI: 10.1002/mus.20889 |
0.15 |
|
| 2008 |
Gold R, Toyka KV. Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, and axonal degeneration and regeneration Neuroimmune Pharmacology. 257-262. DOI: 10.1007/978-0-387-72573-4_19 |
0.15 |
|
| 2015 |
Simon CM, Rauskolb S, Gunnersen JM, Holtmann B, Drepper C, Dombert B, Braga M, Wiese S, Jablonka S, Pühringer D, Zielasek J, Hoeflich A, Silani V, Wolf E, Kneitz S, ... ... Toyka KV, et al. Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy. Acta Neuropathologica. PMID 26025657 DOI: 10.1007/S00401-015-1446-8 |
0.149 |
|
| 2002 |
Buchwald B, Ahangari R, Toyka KV. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction. Neuroscience Letters. 334: 25-8. PMID 12431767 DOI: 10.1016/S0304-3940(02)01037-6 |
0.147 |
|
| 2005 |
Gold R, Bayas A, Toyka KV. Autoimmune neuropathien - Current aspects of immunopathologic diagnostics and therapy | Immunneuropathien - Aktuelle aspekte der diagnostik und therapie Nervenarzt. 76: 1009-1023. PMID 16080020 DOI: 10.1007/s00115-005-1942-5 |
0.146 |
|
| 2005 |
Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M, Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Annals of Neurology. 58: 50-7. PMID 15912506 DOI: 10.1002/ana.20514 |
0.146 |
|
| 2009 |
Geis C, Beck M, Jablonka S, Weishaupt A, Toyka KV, Sendtner M, Sommer C. Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons. Neurobiology of Disease. 36: 191-9. PMID 19631746 DOI: 10.1016/J.Nbd.2009.07.011 |
0.146 |
|
| 2006 |
Hofstetter HH, Lühder F, Toyka KV, Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine. 34: 184-97. PMID 16815032 DOI: 10.1016/j.cyto.2006.04.014 |
0.144 |
|
| 2007 |
Schneider-Gold C, Toyka KV. Myasthenia gravis: Pathogenesis and immunotherapy | Myasthenia gravis: Pathogenese und immuntherapie Deutsches Arzteblatt. 104: 420-426. |
0.143 |
|
| 2016 |
Ip CW, Isaias IU, Kusche-Tekin BB, Klein D, Groh J, O'Leary A, Knorr S, Higuchi T, Koprich JB, Brotchie JM, Toyka KV, Reif A, Volkmann J. Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury. Acta Neuropathologica Communications. 4: 108. PMID 27716431 DOI: 10.1186/S40478-016-0375-7 |
0.142 |
|
| 2021 |
Baum P, Toyka KV, Blüher M, Kosacka J, Nowicki M. Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)-New Aspects. International Journal of Molecular Sciences. 22. PMID 34639176 DOI: 10.3390/ijms221910835 |
0.142 |
|
| 2022 |
Sekhniashvili M, Bodechtel U, Toyka KV, Baum P. Temporary reversal of nerve and muscle dysfunction by serial electrical stimulation in critical illness neuromyopathy. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 142: 244-253. PMID 36084575 DOI: 10.1016/j.clinph.2022.07.509 |
0.141 |
|
| 2005 |
Hartung HP, Kieseier BC, Gold R, Stoll G, Toyka KV. Introduction to Immune Reactions in the Peripheral Nervous System Peripheral Neuropathy. 1: 559-572. DOI: 10.1016/B978-0-7216-9491-7.50028-4 |
0.14 |
|
| 2015 |
Werner C, Haselmann H, Weishaupt A, Toyka KV, Sommer C, Geis C. Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 357-62. PMID 24990310 DOI: 10.1007/s00702-014-1268-1 |
0.14 |
|
| 2003 |
Gold R, Dalakas MC, Toyka KV. Immunotherapy in autoimmune neuromuscular disorders. The Lancet. Neurology. 2: 22-32. PMID 12849298 DOI: 10.1016/S1474-4422(03)00264-3 |
0.139 |
|
| 2005 |
Gold R, Stoll G, Kieseier BC, Hartung HP, Toyka KV. Experimental Autoimmune Neuritis Peripheral Neuropathy. 1: 609-633. DOI: 10.1016/B978-0-7216-9491-7.50030-2 |
0.139 |
|
| 2002 |
Toyka KV, Zielasek J, Stoll G. Myelin-derived glycolipids and animal models of Guillain-Barré syndrome. Annals of Neurology. 51: 532; author reply 53. PMID 11921062 DOI: 10.1002/ana.10140 |
0.138 |
|
| 2001 |
Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV. Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability Multiple Sclerosis. 7: 327-334. PMID 11724449 DOI: 10.1191/135245801681138031 |
0.136 |
|
| 2011 |
Geis C, Weishaupt A, Grünewald B, Wultsch T, Reif A, Gerlach M, Dirkx R, Solimena M, Perani D, Heckmann M, Toyka KV, Folli F, Sommer C. Human stiff-person syndrome IgG induces anxious behavior in rats. Plos One. 6: e16775. PMID 21346811 DOI: 10.1371/Journal.Pone.0016775 |
0.135 |
|
| 2002 |
Schäfers M, Schmidt C, Vogel C, Toyka KV, Sommer C. Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve. Acta Neuropathologica. 104: 197-205. PMID 12111363 DOI: 10.1007/s00401-002-0541-9 |
0.134 |
|
| 2007 |
Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. Journal of Immunology (Baltimore, Md. : 1950). 178: 1372-8. PMID 17237384 |
0.133 |
|
| 2003 |
Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, Sommer C. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP Neurology. 61: 1607-1610. PMID 14663052 |
0.133 |
|
| 2014 |
Niemann A, Huber N, Wagner KM, Somandin C, Horn M, Lebrun-Julien F, Angst B, Pereira JA, Halfter H, Welzl H, Feltri ML, Wrabetz L, Young P, Wessig C, Toyka KV, et al. The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease. Brain : a Journal of Neurology. 137: 668-82. PMID 24480485 DOI: 10.1093/Brain/Awt371 |
0.13 |
|
| 2008 |
Gold R, Hohlfeld R, Toyka KV. Progress in the treatment of myasthenia gravis. Therapeutic Advances in Neurological Disorders. 1: 36-51. PMID 21180568 DOI: 10.1177/1756285608093888 |
0.13 |
|
| 2005 |
Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cellular Immunology. 237: 123-30. PMID 16386239 DOI: 10.1016/j.cellimm.2005.11.002 |
0.13 |
|
| 2004 |
Kroner A, Mäurer M, Loserth S, Kleinschnitz C, Hemmer B, Rosche B, Toyka KV, Rieckmann P. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis Tissue Antigens. 64: 70-73. PMID 15191525 DOI: 10.1111/j.1399-0039.2004.00240.x |
0.129 |
|
| 2014 |
Krieger F, Elflein N, Saenger S, Wirthgen E, Rak K, Frantz S, Hoeflich A, Toyka KV, Metzger F, Jablonka S. Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1. Brain : a Journal of Neurology. 137: 1374-93. PMID 24681663 DOI: 10.1093/brain/awu059 |
0.128 |
|
| 2003 |
Müllges W, Gold R, Toyka KV. Myasthenic crisis | Myasthene krise Intensivmedizin Und Notfallmedizin. 40: 111-123. DOI: 10.1007/s00390-003-0369-0 |
0.127 |
|
| 2019 |
Kosacka J, Woidt K, Toyka KV, Paeschke S, Klöting N, Bechmann I, Blüher M, Thiery J, Ossmann S, Baum P, Nowicki M. The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice. Neurological Research. 1-13. PMID 30638160 DOI: 10.1080/01616412.2018.1564191 |
0.127 |
|
| 2000 |
George A, Marziniak M, Schäfers M, Toyka KV, Sommer C. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin Pain. 88: 267-275. PMID 11068114 DOI: 10.1016/S0304-3959(00)00333-X |
0.126 |
|
| 2012 |
Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. The Cochrane Database of Systematic Reviews. 12: CD002277. PMID 23235588 DOI: 10.1002/14651858.Cd002277.Pub4 |
0.125 |
|
| 2006 |
Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis Multiple Sclerosis. 12: 58-65. PMID 16459720 DOI: 10.1191/135248506ms1244oa |
0.122 |
|
| 2003 |
Korn T, Fischer KD, Girkontaite I, Köllner G, Toyka K, Jung S. Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming. Journal of Neuroimmunology. 139: 17-26. PMID 12799016 DOI: 10.1016/S0165-5728(03)00128-0 |
0.12 |
|
| 2002 |
Bayas A, Hummel V, Kallmann BA, Karch C, Toyka KV, Rieckmann P. Human cerebral endothelial cells are a potential source for bioactive BDNF Cytokine. 19: 55-58. PMID 12182839 DOI: 10.1006/cyto.2002.0892 |
0.119 |
|
| 2023 |
Sekhniashvili M, Baum P, Toyka KV. Temporary and highly variable recovery of neuromuscular dysfunction by electrical stimulation in the follow-up of acute critical illness neuromyopathy: a pilot study. Neurological Research and Practice. 5: 66. PMID 38151742 DOI: 10.1186/s42466-023-00293-1 |
0.119 |
|
| 2020 |
Pereira JA, Gerber J, Ghidinelli M, Gerber D, Tortola L, Ommer A, Bachofner S, Santarella F, Tinelli E, Lin S, Rüegg MA, Kopf M, Toyka KV, Suter U. Mice carrying an analogous heterozygous Dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy. Human Molecular Genetics. PMID 32129442 DOI: 10.1093/Hmg/Ddaa034 |
0.119 |
|
| 2001 |
Büttner U, Chofflon M, Hess K, Kappos L, Kesselring J, Ludin HP, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Freimüller M, Hartung HP, Kollegger H, Kristoferitsch W, ... ... Toyka KV, et al. Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement | Immunmodulatorische stufentherapie der multiplen sklerose. 1. Ergänzung: Dezember 2000 Nervenarzt. 72: 150-157. PMID 11256151 DOI: 10.1007/s001150050729 |
0.117 |
|
| 2002 |
Giess R, Mäurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P. Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Archives of Neurology. 59: 407-9. PMID 11890844 DOI: 10.1001/Archneur.59.3.407 |
0.116 |
|
| 2009 |
Buttmann M, Toyka KV. Can we get rid of neutralizing antibodies against interferon-β?: EDITORIAL European Journal of Neurology. 16: 7-9. PMID 19087143 DOI: 10.1111/j.1468-1331.2008.02333.x |
0.116 |
|
| 2004 |
Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, et al. Escalating immunotherapy of multiple sclerosis--new aspects and practical application. Journal of Neurology. 251: 1329-39. PMID 15592728 DOI: 10.1007/s00415-004-0537-6 |
0.115 |
|
| 2002 |
Weiss H, Rastan V, Müllges W, Wagner RF, Toyka KV. Psychotic symptoms and emotional distress in patients with Guillain-Barré syndrome European Neurology. 47: 74-78. PMID 11844894 DOI: 10.1159/000047956 |
0.111 |
|
| 2012 |
Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors. Experimental Neurology. 237: 286-95. PMID 22789393 DOI: 10.1016/J.Expneurol.2012.06.034 |
0.11 |
|
| 2003 |
Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G. In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 23: 1356-61. PMID 14600443 DOI: 10.1097/01.WCB.0000090505.76664.DB |
0.109 |
|
| 2005 |
Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV, Naumann M. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 6: 100-3. PMID 16036433 DOI: 10.1080/14660820510028412 |
0.107 |
|
| 2011 |
Hummel HD, Rath JC, Wiendl H, Hetzel W, Bargou RC, Toyka KV, Sommer C, Einsele H, Topp MS. Auto-SCT in severe paraproteinemic neuropathy Bone Marrow Transplantation. 46: 457-459. PMID 20577220 DOI: 10.1038/bmt.2010.124 |
0.107 |
|
| 2003 |
Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I, Karageorgiou C, Nobile-Orazio E, van den Bergh P, Swan T, Hughes R, Aubry J, Baumann N, Hadden R, Lunn M, ... ... Toyka K, et al. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. Journal of Neurology. 249: 1370-7. PMID 12382151 DOI: 10.1007/s00415-002-0808-z |
0.107 |
|
| 2012 |
Brecht I, Weissbrich B, Braun J, Toyka KV, Weishaupt A, Buttmann M. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. Plos One. 7: e40431. PMID 22792316 DOI: 10.1371/journal.pone.0040431 |
0.107 |
|
| 2005 |
Kroner A, Vogel F, Kolb-Mäurer A, Kruse N, Toyka KV, Hemmer B, Rieckmann P, Mäurer M. Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis Journal of Neuroimmunology. 165: 161-165. PMID 15932772 DOI: 10.1016/j.jneuroim.2005.03.012 |
0.107 |
|
| 2002 |
Buttman M, Marziniak M, Toyka KV, Sommer C, Altland K. "sporadic" familial amyloidotic polyneuropathy in a German patient with B cell lymphocytic leukaemia [1] Journal of Neurology Neurosurgery and Psychiatry. 73: 86-87. PMID 12082059 DOI: 10.1136/jnnp.73.1.86 |
0.106 |
|
| 2001 |
Gold R, Buttgereit F, Toyka KV. Mechanism of action of glucocorticosteroid hormones: Possible implications for therapy of neuroimmunological disorders Journal of Neuroimmunology. 117: 1-8. PMID 11430999 DOI: 10.1016/S0165-5728(01)00330-7 |
0.104 |
|
| 2003 |
Wolinsky JS, Toyka KV, Kappos L, Grossberg SE. Interferon-beta antibodies: implications for the treatment of MS. The Lancet. Neurology. 2: 528. PMID 12941572 DOI: 10.1016/S1474-4422(03)00499-X |
0.103 |
|
| 2002 |
Kahl KG, Kruse N, Toyka KV, Rieckmann P. Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis. Journal of the Neurological Sciences. 200: 53-5. PMID 12127676 DOI: 10.1016/S0022-510X(02)00136-3 |
0.103 |
|
| 2001 |
Kieseier BC, Schneider C, Clements JM, Gearing AJH, Gold R, Toyka KV, Hartung HP. Expression of specific matrix metalloproteinases in inflammatory myopathies Brain. 124: 341-351. PMID 11157561 DOI: 10.1093/Brain/124.2.341 |
0.103 |
|
| 2002 |
Rieckmann P, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, ... ... Toyka KV, et al. Escalating immunomodulatory therapy of multiple sclerosis - New aspects and practical application | Immunmodulatorische stufentherapie der multiplen sklerose: Neue aspekte und praktische umsetzung, März 2002 Nervenarzt. 73: 556-563. PMID 12243005 DOI: 10.1007/s00115-002-1328-x |
0.102 |
|
| 2009 |
Gold R, Hartung HP, Hohlfeld R, Wiendl H, Kieseier BC, Linker RA, Schmidt S, Toyka KV, Adams O, Baum K, Bayas A, Bitsch A, Buck D, Chan A, Derfuß T, et al. Therapy of multiple sclerosis with monoclonal antibodies: Results and recommendations of a symposium of the medical advisory board of the german MS society | Therapie der multiplen sklerose mit monoklonalen antikörpern: Ergebnisse und empfehlungen einer arbeitstagung des ärztlichen beirats der deutschen multiple sklerose gesellschaft Aktuelle Neurologie. 36: 334-344. DOI: 10.1055/s-0029-1220429 |
0.102 |
|
| 2006 |
Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of multiple sclerosis: Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society European Neurology. 56: 78-105. PMID 16966832 DOI: 10.1159/000095699 |
0.102 |
|
| 2005 |
Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis Cochrane Database of Systematic Reviews (Online). CD002828. PMID 15846640 |
0.101 |
|
| 2009 |
Bertram S, Zhang W, Toyka K, Hatt H, Eder M, Buchwald B. Immunoglobulin G from patients with chronic inflammatory demyelinating polyneuropathy (CIDP) affects presynaptic transmitter release and calcium influx Pharmacopsychiatry. 42. DOI: 10.1055/s-0029-1240083 |
0.1 |
|
| 2014 |
Nowicki M, Baum P, Kosacka J, Stockinger M, Klöting N, Blüher M, Bechmann I, Toyka KV. Effects of isoflurane anesthesia on F-waves in the sciatic nerve of the adult rat. Muscle & Nerve. 50: 257-61. PMID 24347162 DOI: 10.1002/mus.24150 |
0.099 |
|
| 2002 |
Flachenecker P, Jung S, Rieckmann P, Toyka KV. sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis--a cross-sectional pilot study. Journal of Neurology. 249: 1001-3. PMID 12195444 DOI: 10.1007/s00415-002-0772-7 |
0.099 |
|
| 2001 |
Schneider C, Gold R, Reiners K, Toyka KV. Mycophenolate mofetil in the therapy of severe myasthenia gravis European Neurology. 46: 79-82. PMID 11528156 DOI: 10.1159/000050768 |
0.099 |
|
| 2002 |
Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: Predictors of survival Muscle and Nerve. 25: 709-714. PMID 11994965 DOI: 10.1002/mus.10090 |
0.099 |
|
| 2004 |
Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, Koch MC, Pongratz DE, Toyka KV, Lochmüller H, Ricker K. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle & Nerve. 29: 275-81. PMID 14755494 DOI: 10.1002/mus.10545 |
0.098 |
|
| 2002 |
Weilbach FX, Toyka KV. Does Down's syndrome protect against multiple sclerosis? European Neurology. 47: 52-55. PMID 11803193 |
0.097 |
|
| 2002 |
Beer M, Schneider C, Köstler H, Buchner S, Sandstede J, Toyka KV, Hahn D. Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy Rofo Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 174: 573-578. PMID 11997856 DOI: 10.1055/s-2002-28273 |
0.097 |
|
| 2002 |
Schneider C, Gold R, Schäfers M, Toyka KV. Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome Muscle and Nerve. 25: 286-288. PMID 11870700 DOI: 10.1002/mus.10026 |
0.097 |
|
| 2000 |
Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: 201-6. PMID 11464953 DOI: 10.1080/14660820050515197 |
0.097 |
|
| 2002 |
Giess R, Holtmann B, Braga M, Grimm T, Müller-Myhsok B, Toyka KV, Sendtner M. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. American Journal of Human Genetics. 70: 1277-86. PMID 11951178 DOI: 10.1086/340427 |
0.096 |
|
| 2001 |
Beer M, Sandstede J, Weilbach F, Spindler M, Buchner S, Krug A, Köstler H, Pabst T, Kenn W, Landschütz W, Von Kienlin M, Toyka KV, Ertl C, Gold R, Hahn D. Cardiac metabolism and function in patients with multiple sclerosis: A combined 31P-MR-spectroscopy and MRI study | Metabolische und funktionelle veränderungen des herzens bel patienten mit multiplier sklerose: Eine MR-spektroskopische und MR-tomographische studie Rofo Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 173: 399-404. PMID 11414146 DOI: 10.1055/s-2001-13339 |
0.095 |
|
| 2019 |
Paeschke S, Baum P, Toyka KV, Blüher M, Koj S, Klöting N, Bechmann I, Thiery J, Kosacka J, Nowicki M. The Role of Iron and Nerve Inflammation in Diabetes Mellitus Type 2-Induced Peripheral Neuropathy. Neuroscience. PMID 30867132 DOI: 10.1016/j.neuroscience.2019.03.005 |
0.095 |
|
| 2016 |
Baum P, Kosacka J, Estrela-Lopis I, Woidt K, Serke H, Paeschke S, Stockinger M, Klöting N, Blüher M, Dorn M, Classen J, Thiery J, Bechmann I, Toyka KV, Nowicki M. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Metabolism: Clinical and Experimental. 65: 391-405. PMID 26975531 DOI: 10.1016/j.metabol.2015.11.002 |
0.095 |
|
| 2004 |
Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Multiple Sclerosis (Houndmills, Basingstoke, England). 10: 165-9. PMID 15124762 DOI: 10.1191/1352458504ms991oa |
0.093 |
|
| 2002 |
Sommer C, Lindenlaub T, Zillikens D, Toyka KV, Naumann M. Selective loss of cholinergic sudomotor fibers causes anhidrosis in Ross syndrome. Annals of Neurology. 52: 247-50. PMID 12210801 DOI: 10.1002/ana.10256 |
0.092 |
|
| 2007 |
Kosinski CM, Schlangen C, Gellerich FN, Gizatullina Z, Deschauer M, Schiefer J, Young AB, Landwehrmeyer GB, Toyka KV, Sellhaus B, Lindenberg KS. Myopathy as a first symptom of Huntington's disease in a Marathon runner. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1637-40. PMID 17534945 DOI: 10.1002/mds.21550 |
0.089 |
|
| 2003 |
Flachenecker P, Schneider C, Cursiefen S, Ricker K, Toyka KV, Reiners K. Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM). Neuromuscular Disorders : Nmd. 13: 289-93. PMID 12868497 DOI: 10.1016/S0960-8966(02)00277-8 |
0.089 |
|
| 2004 |
Johannssen K, Rupprecht K, Toyka KV, Mäurer M. Primary progressive multiple sclerosis: Usage of new recommended guidelines prevents misdiagnosis | Primär chronisch progrediente multiple sklerose (MS): Das einhalten der neuen diagnostischen kriterien verhindert fehldiagnosen Aktuelle Neurologie. 31: 407-410. DOI: 10.1055/s-2004-828364 |
0.089 |
|
| 2017 |
Grünewald B, Lange MD, Werner C, O'Leary A, Weishaupt A, Popp S, Pearce DA, Wiendl H, Reif A, Pape HC, Toyka KV, Sommer C, Geis C. Defective synaptic transmission causes disease signs in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis. Elife. 6. PMID 29135436 DOI: 10.7554/Elife.28685 |
0.089 |
|
| 2002 |
Giess R, Werner E, Beck M, Reiners C, Toyka KV, Naumann M. Impaired salivary gland function reveals autonomic dysfunction in amyotrophic lateral sclerosis Journal of Neurology. 249: 1246-1249. PMID 12242548 DOI: 10.1007/s00415-002-0820-3 |
0.088 |
|
| 2001 |
Hummel V, Kallmann BA, Wagner S, Füller T, Bayas A, Tonn JC, Benveniste EN, Toyka KV, Rieckmann P. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. Journal of Neuropathology and Experimental Neurology. 60: 320-7. PMID 11305867 DOI: 10.1093/Jnen/60.4.320 |
0.085 |
|
| 2007 |
Uçeyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology. 69: 42-9. PMID 17606879 DOI: 10.1212/01.wnl.0000265062.92340.a5 |
0.084 |
|
| 2003 |
Flachenecker P, Rufer A, Bihler I, Hippel C, Reiners K, Toyka KV, Kesselring J. Fatigue in MS is related to sympathetic vasomotor dysfunction Neurology. 61: 851-853. PMID 14504339 |
0.083 |
|
| 2004 |
Schneider-Gold C, Beer M, Köstler H, Buchner S, Sandstede J, Hahn D, Toyka KV. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle & Nerve. 30: 636-44. PMID 15452841 DOI: 10.1002/mus.20156 |
0.083 |
|
| 2010 |
Zeller D, Aufm Kampe K, Biller A, Stefan K, Gentner R, Schütz A, Bartsch A, Bendszus M, Toyka KV, Rieckmann P, Classen J. Rapid-onset central motor plasticity in multiple sclerosis Neurology. 74: 728-735. PMID 20194911 DOI: 10.1212/WNL.0b013e3181d31dcf |
0.083 |
|
| 2002 |
Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, Trenkwalder C, Toyka KV. Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters Multiple Sclerosis. 8: 523-526. PMID 12474995 DOI: 10.1191/1352458502ms839oa |
0.083 |
|
| 2007 |
Beck M, Sendtner M, Toyka KV. Novel SOD1 N86K mutation is associated with a severe phenotype in familial ALS. Muscle & Nerve. 36: 111-4. PMID 17299743 DOI: 10.1002/Mus.20756 |
0.081 |
|
| 2016 |
Buttmann M, Seuffert L, Mäder U, Toyka KV. Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study. Neurology. PMID 27170571 DOI: 10.1212/WNL.0000000000002745 |
0.081 |
|
| 2012 |
Zeller D, Dang SY, Weise D, Rieckmann P, Toyka KV, Classen J. Excitability decreasing central motor plasticity is retained in multiple sclerosis patients. Bmc Neurology. 12: 92. PMID 22974055 DOI: 10.1186/1471-2377-12-92 |
0.081 |
|
| 2007 |
Chan A, Lee DH, Linker R, Mohr A, Toyka KV, Gold R. Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease. Journal of Neurology. 254: 1604-6. PMID 17713826 DOI: 10.1007/S00415-007-0593-9 |
0.08 |
|
| 2001 |
Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology. 56: 758-65. PMID 11274311 |
0.077 |
|
| 2015 |
Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, ... ... Toyka KV, et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. Jama Neurology. 1-7. PMID 26349037 DOI: 10.1001/Jamaneurol.2015.2101 |
0.076 |
|
| 2001 |
Flachenecker P, Toyka KV, Reiners K. Cardiac arrhythmias in Guillain-Barré syndrome: A review of the diagnosis of rare but potentially life-threatening complications | Herzrhythmusstörungen beim Guillain-Barré-syndrom: Eine übersicht zur diagnostik einer seltenen, aber potenziell lebensbedrohlichen komplikation Nervenarzt. 72: 610-617. PMID 11519201 DOI: 10.1007/s001150170060 |
0.075 |
|
| 2000 |
Kress W, Mueller-Myhsok B, Ricker K, Schneider C, Koch MC, Toyka KV, Mueller CR, Grimm T. Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2). Neuromuscular Disorders : Nmd. 10: 478-80. PMID 10996776 DOI: 10.1016/S0960-8966(00)00129-2 |
0.075 |
|
| 2022 |
Hoffmann Y, Toyka KV, Blüher M, Classen J, Baum P. Functional predictors of treatment induced diabetic neuropathy (TIND): a prospective pilot study using clinical and neurophysiological functional tests. Diabetology & Metabolic Syndrome. 14: 35. PMID 35241138 DOI: 10.1186/s13098-022-00805-0 |
0.075 |
|
| 2008 |
Gold R, Schneider-Gold C, Toyka KV. Progress in pathogenesis and treatment of myasthenia gravis and lambert eaton myasthenic syndrome | Fortschritte in pathogenese und therapie der myasthenia gravis und des lambert-eaton-myasthenen syndroms Aktuelle Neurologie. 35: 192-203. DOI: 10.1055/s-2007-986407 |
0.073 |
|
| 2010 |
Kraft P, Beck M, Grimm A, Wessig C, Reiners K, Toyka KV. Amyotrophic lateral sclerosis: Management of bulbar symptoms | Amyotrophe Lateralsklerose: Symptomatische therapie bulbärer symptome Nervenarzt. 81: 1218-1225. PMID 20401600 DOI: 10.1007/s00115-010-3008-6 |
0.072 |
|
| 2020 |
Huehnchen P, Toyka KV, Gertz K, Endres M, Boehmerle W. Focal brain ischemia in mice does not cause electrophysiological signs of critical illness neuropathy. Bmc Research Notes. 13: 425. PMID 32912287 DOI: 10.1186/s13104-020-05248-2 |
0.07 |
|
| 2002 |
Flachenecker P, Toyka KV, Reiners K. Diagnosis of autonomic dysfunction in Guillain-Barré syndrome | Diagnostik kardiovaskulärer autonomer störungen beim Guillain-Barré-syndrom Intensiv- Und Notfallbehandlung. 27: 120-130. |
0.07 |
|
| 2016 |
Kosacka J, Klöting N, Nowicki M, Baum P, Stumvoll M, Paeschke S, Toyka K, Bechmann I, Blüher M. Role of autophagy in adipose tissue and in peripheral nervous system in diabetes type 2, obesity and metabolic syndrome Diabetologie Und Stoffwechsel. 11. DOI: 10.1055/s-0036-1584106 |
0.069 |
|
| 2003 |
Schneider-Gold C, Beck M, Wessig C, George A, Kele H, Reiners K, Toyka KV. Creatine monohydrate in DM2/PROMM: A double-blind placebo-controlled clinical study Neurology. 60: 500-502. PMID 12578937 |
0.068 |
|
| 2009 |
Flachenecker P, Leussink V, Frischholz C, Schoof J, Brechtelsbauer D, Reiners K, Toyka K, Rieckmann P. Autonome kardiovasuläre Regulationsstörung bei Patienten mit klinisch isoliertem Syndrom und Multiple Sklerose: eine prospektive Längsschnittuntersuchung Aktuelle Neurologie. 36. DOI: 10.1055/s-0029-1238572 |
0.068 |
|
| 2001 |
Weilbach FX, Rieckmann P, Gold R, Toyka KV. Multiple sclerosis: Critical discussion of controversial and complementary therapies based on current pathogenetic hypotheses | Multiple sklerose: Kritische betrachtung umstrittener und komplementärmedizinischer therapien auf der grundlage aktueller hypothesen zur pathogenese Aktuelle Neurologie. 28: 31-38. DOI: 10.1055/s-2001-10721 |
0.067 |
|
| 2011 |
Hohlfeld R, Toyka KV. Multiple sclerosis: Updates on pathogenesis and therapy. Report from the 9th MS Symposium of the German Multiple Sclerosis Society | Multiple Sklerose: Updates zu pathogenese und therapie: Bericht vom 9. MS-symposium der deutschen multiplen sklerose gesellschaft Nervenarzt. 82: 1026-1035. PMID 21424411 DOI: 10.1007/s00115-011-3264-0 |
0.066 |
|
| 2005 |
Bates D, Toyka KV, Wolinsky JS, Arnold D. Disease management in multiple sclerosis. European Neurology. 53: 203-5. PMID 15976505 DOI: 10.1159/000086480 |
0.062 |
|
| 2003 |
Toyka KV, Schneider-Gold C. Oculomotor signs in Lambert-Eaton myasthenic syndrome-coincidence with myasthenia gravis. Annals of Neurology. 54: 135-6; author reply . PMID 12838533 DOI: 10.1002/ana.10640 |
0.062 |
|
| 2004 |
Henze T, Toyka KV. Treatment of multiple sclerosis symptoms: The necessity of guidelines | Therapie von MS-symptomen: Auch hier sind leitlinien notwendig Nervenarzt. 75: S1. PMID 15480525 |
0.061 |
|
| 2004 |
Ströbel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, Schalke B, Müller-Hermelink HK, Marx A. Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective Analysis Journal of Clinical Oncology. 22: 1501-1509. PMID 15084623 DOI: 10.1200/Jco.2004.10.113 |
0.06 |
|
| 2008 |
Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, et al. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations Journal of Neurology. 255: 1449-1463. PMID 19005625 DOI: 10.1007/s00415-008-0061-1 |
0.058 |
|
| 2002 |
Hoffmann V, Hardt C, Mäurer M, Linker R, Gold R, Toyka KV, Sendtner M, Rieckmann P. A null mutation in the CNTF gene is not associated with early onset of multiple sclerosis [2] (multiple letters) Archives of Neurology. 59: 1974-1975. PMID 12470191 DOI: 10.1001/archneur.59.12.1974 |
0.055 |
|
| 2003 |
Toyka KV. Therapeutic value of azathioprine in myasthenia gravis statement of the German neurological society | Therapeutischer stellenwert von azathioprin bei der behandlung der myasthenia gravis: Stellungnahme der Deutschen gesellschaft für neurologie Aktuelle Neurologie. 30: 1-2. DOI: 10.1055/s-2003-37064 |
0.055 |
|
| 2016 |
Schneider-Gold C, Krenzer M, Klinker E, Mansouri-Thalegani B, Müllges W, Toyka KV, Gold R. Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration. Therapeutic Advances in Neurological Disorders. 9: 297-303. PMID 27366236 DOI: 10.1177/1756285616637046 |
0.054 |
|
| 2006 |
Schneider-Gold C, Wessig C, Höpker M, Erdlenbruch B, Gold R, Toyka K. Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome. Journal of Neurology. 253: 1236-7. PMID 16598612 DOI: 10.1007/s00415-006-0150-y |
0.054 |
|
| 2003 |
Hohlfeld R, Melms A, Schneider C, Toyka KV, Drachman DB. Therapy of Myasthenia Gravis and Myasthenic Syndromes Neurological Disorders: Course and Treatment: Second Edition. 1341-1362. DOI: 10.1016/B978-012125831-3/50289-6 |
0.052 |
|
| 2004 |
Bendszus M, Koltzenburg M, Bartsch AJ, Goldbrunner R, Günthner-Lengsfeld T, Weilbach FX, Roosen K, Toyka KV, Solymosi L. Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography: a prospective, randomized trial. Circulation. 110: 2210-5. PMID 15466635 DOI: 10.1161/01.CIR.0000144301.82391.85 |
0.052 |
|
| 2011 |
Zeller D, Dang SY, Stefan K, Biller A, Bartsch A, Saur D, Bendszus M, Rieckmann P, Toyka KV, Classen J. Functional role of ipsilateral motor areas in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 578-83. PMID 20980484 DOI: 10.1136/jnnp.2010.219964 |
0.05 |
|
| 2002 |
Müllges W, Babin-Ebell J, Reents W, Toyka KV. Cognitive performance after coronary artery bypass grafting: a follow-up study. Neurology. 59: 741-3. PMID 12221167 |
0.047 |
|
| 2001 |
Winterholler MGM, Erbguth FJ, Wolf S, Kat S, Naumann M, Giess R, Schwager K, Toyka KV. Botulinum toxin for the treatment of sialorrhoea in ALS: Serious side effects of a transductal approach [13] (multiple letters) Journal of Neurology Neurosurgery and Psychiatry. 70: 417-418. PMID 11248905 DOI: 10.1136/jnnp.70.3.417 |
0.046 |
|
| 2004 |
Spech E, Kallmann B, Kroner A, Petzold A, Miller D, Thompson A, Giovannoni G, Toyka K, Rieckmann P. Unterschiede im Genexpressionsmuster bei schubförmiger und primär progredienter Multipler Sklerose Aktuelle Neurologie. 31. DOI: 10.1055/s-2004-833320 |
0.044 |
|
| 2006 |
Toyka KV. Ptosis in myasthenia gravis: extended fatigue and recovery bedside test. Neurology. 67: 1524. PMID 17060601 DOI: 10.1212/01.wnl.0000240069.24338.c8 |
0.029 |
|
| 1997 |
Ochs G, Schrank B, Toyka K, Sendtner M. Neurotrophe Faktoren in der Therapie neurologischer Erkrankungen Aktuelle Neurologie. 24: 170-174. DOI: 10.1055/s-2007-1017804 |
0.029 |
|
| 2003 |
Müllges W, Franke D, Reents W, Babin-Ebell J, Toyka KV. Reduced rate of microembolism by optimized aortic cannula position does not influence early postoperative cognitive performance in CABG patients. Cerebrovascular Diseases (Basel, Switzerland). 15: 192-8. PMID 12646779 DOI: 10.1159/000068827 |
0.026 |
|
| 2005 |
Korn T, Magnus T, Voss J, Schrempf W, Toyka K, Jung S. Leflunomid moduliert neuroinflammatorische Effektorzellen unabhängig von seiner Pyrimidin-depletierenden Wirkung. - Eine neue Option für die orale Behandlung der Multiplen Sklerose? Aktuelle Neurologie. 32. DOI: 10.1055/s-2005-919604 |
0.025 |
|
| 2002 |
Toyka KV, Müller B, Reichmann H. "Atraumatic" Sprotte needle reduces the incidence of post-lumbar puncture headaches. Neurology. 59: 1120; author reply 1. PMID 12370487 |
0.025 |
|
| 2011 |
Latov N, Dalakas M, Vallat JM, Donofrio P, Hartung HP, Toyka KV. Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece. Journal of the Peripheral Nervous System : Jpns. 16: 1-2. PMID 21696489 DOI: 10.1111/J.1529-8027.2011.00297.X |
0.024 |
|
| 2022 |
McArthur JC, Toyka K, Hoke A. In memoriam: Daniel B. Drachman. Annals of Neurology. PMID 36468201 DOI: 10.1002/ana.26565 |
0.022 |
|
| 2004 |
Kallmann B, Büttner S, Toyka K, Reiners K, Rieckmann P. Prognostischer Wert von evozierten Potentialen für den Krankheitsverlauf bei der Multiplen Sklerose Aktuelle Neurologie. 31. DOI: 10.1055/s-2004-833093 |
0.019 |
|
| Hide low-probability matches. |